Concepedia

Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects

Mary Jeanne DeLeon, Vikram Chandurkar, Stewart G. Albert, Arshag D. Mooradian

Diabetes Research and Clinical Practice · 2002 · 40 citations · 14 references

Concepts

MedicineEndocrinologyGeriatric MedicineAgingDiabetologySignal TransductionDiabetes ControlDiabetes MellitusGlucagon-like Peptide-1 Receptor AgonistsGlycemic ControlInsulin ResistanceOral Antidiabetic AgentsGlucagon-like Peptide 1 Receptor AgonismGlucagon-like Peptide 1 SignalingGlucagon-like Peptide-1 Receptor SignalingGlucagon-like Peptides

References

14

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Diabetes Care · 2002 · 10.4K citations

Medicine, Endocrinology, Internal Medicine +11

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Diabetes Care · 1997 · 6.2K citations

Medicine, Endocrinology, Internal Medicine +11

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

Michael A. Nauck, Markus M. Heimesaat, Jens J. Holst et al. · Journal of Clinical Investigation · 1993 · 1.6K citations · Full text

Medicine, Endocrinology, Pharmacology +15

Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

Tina Vilsbøll, Thure Krarup, Carolyn F. Deacon et al. · Diabetes · 2001 · 884 citations · Full text

Medicine, Endocrinology, Nutrition +16

Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility

Caroline G. MacIntosh, Jane M. Andrews, Karen L. Jones et al. · American Journal of Clinical Nutrition · 1999 · 249 citations

Medicine, Endocrinology, Aging +12